Actively Recruiting

Phase 3
Age: 0 - 18Years
All Genders
NCT04499755

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Led by Sherief Abd-Elsalam · Updated on 2020-08-05

100

Participants Needed

1

Research Sites

549 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

CONDITIONS

Official Title

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Who Can Participate

Age: 0 - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children with traumatic brain injury: Moderate and Severe.
Not Eligible

You will not qualify if you...

  • Underlying CNS disorders,

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Sherief Abd-Elsalam

Tanta, Egypt

Actively Recruiting

Loading map...

Research Team

S

Sherief Abd-Elsalam, ass. prof.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here